Skip to content

Stenting for Symptomatic Intracranial Artery Stenosis Registry in China

Stenting for Symtomatic Intracranial Artery Stenosis Registry in China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01830413
Enrollment
450
Registered
2013-04-12
Start date
2013-04-30
Completion date
2013-12-31
Last updated
2013-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systematic Intracranial Artery Stenosis

Keywords

stent, systematic Intracranial artery stenosis

Brief summary

Stenting for systematic Intracranial artery stenosis is challenged recently, especially for safety. This registry is aimed to explore the safety profile during peri-operation period in Stenting procedures for systematic Intracranial artery stenosis in Chinese population in real world.

Interventions

None listed

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18-80 year old * medical failure patient with systematic Intracranial artery stenosis * More than 3 weeks after most recent ischemic stroke * Digital Subtraction Angiography(DSA) showed ≥70% stenosis in target intracranial artery * Imaging test within 1 week showed bad collateral circulation in target vessel area * Diseased vessel diameter≥2mm, length \<15mm, distal vessel is normal

Exclusion criteria

* Diffused intracranial stenosis * Acute stroke or TIA within 3 weeks * Pure penetrating branch stenosis showed by cerebral imaging * Non-atherosclerosis pathology for the stenosis * Intracranial hemorrhage in target vessel area within 6 weeks; or potential cardiac thrombus source * Intracranial tumor, arterial aneurysm or intracranial arteriovenous malformation •\>50% stenosis in extracranial carotid artery or vertebral artery in operation side; Known contradiction to heparin, aspirin, clopidogrel, anesthesia or contrast; hemoglobin \<10g/dl,platelet count \<100000 * Modified Rankin score ≥3 related to target vessel; * INR(International Normalized Ratio)\>1.5(irreversible),persist hemorrhage risk; life expectancy \< 1year * Pregnant or beast-feeding * Not suitable for endovascular stenting judged by Indication Judgement Committee

Design outcomes

Primary

MeasureTime frameDescription
Safety during peri-operation period30 days after operationStroke in target cerebral vessel or death within 30 days after stenting procedure for systematic Intracranial artery stenosis

Secondary

MeasureTime frameDescription
Successful recanalization rate right after stentingright after stenting
Stent restenosis rateWithin 1 year after stenting
Ischemic stroke outside target vessel area30 days - 1 year after stenting
Cerebral haemorrhage30 days - 1year after
Myocardial infarctionwithin 1 year
non-stroke haemorrhagewithin 1year
Death in 30 days- 1 year after stenting30 days- 1 year after stenting
Recurrent stroke in 30days to 1 year after stenting in target vessel area.30days to 1 year after stentingRecurrent stroke in 30days to 1 year after stenting in target vessel area.
Any stroke or deathwithin 1 year
Serious adverse eventwithin 1year
National Institutes of Health Stroke Scale score(NIHSS score)at 30 days and 1 year after stenting
Modified Rankin score(mRS)at 30 days and 1 year after stenting
MoCA scale scoreat 30 days and 1 year after stenting
Life quality scale scoreat 1 year after stenting
disabled strokewithin 1year

Countries

China

Contacts

Primary Contactyilong Wang, M.D.
yilong528@gmail.com86-13911666571

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026